SGLT2 inhibitors: cardiorenal metabolic drugs for the ages

Producción científica: Short survey › revisión exhaustiva

Idioma original	English (US)
Número de artículo	e177625
Publicación	Journal of Clinical Investigation
Volumen	134
N.º	5
DOI	https://doi.org/10.1172/JCI177625
Estado	Published - mar 1 2024
Publicado de forma externa	Sí

ASJC Scopus subject areas

@article{80ece8a02d2648d1afc6173d1a9477fe,

title = "SGLT2 inhibitors: cardiorenal metabolic drugs for the ages",

author = "DeFronzo, \{Ralph A.\}",

year = "2024",

month = mar,

day = "1",

doi = "10.1172/JCI177625",

language = "English (US)",

volume = "134",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "American Society for Clinical Investigation",

number = "5",

}

TY - JOUR

T1 - SGLT2 inhibitors

T2 - cardiorenal metabolic drugs for the ages

AU - DeFronzo, Ralph A.

PY - 2024/3/1

Y1 - 2024/3/1

UR - https://www.scopus.com/pages/publications/85186303389

UR - https://www.scopus.com/pages/publications/85186303389#tab=citedBy

U2 - 10.1172/JCI177625

DO - 10.1172/JCI177625

M3 - Short survey

C2 - 38426504

AN - SCOPUS:85186303389

SN - 0021-9738

VL - 134

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 5

M1 - e177625

ER -